Alcon爱尔康品牌怎么样 申请店铺

我要投票 Alcon爱尔康在医疗器械行业中的票数:1047 更新时间:2026-01-03
Alcon爱尔康是哪个国家的品牌?「Alcon爱尔康」是爱尔康(中国)眼科产品有限公司旗下著名品牌。该品牌发源于美国,在1945年期间创立,经过多年的不懈努力和高速发展,现已成为行业的标杆品牌。

外推网助力Alcon爱尔康品牌出海!将品牌入驻外推网,定制Alcon爱尔康品牌推广信息,可以显著提高Alcon爱尔康产品曝光,简直是跨境电商爆单神器!目前仅需1000元/年哦~

Alcon爱尔康怎么样

始于1945年美国,2008年被诺华公司收购,全球眼科领域的领先者,专业研究、发展、服务及制造光学及眼科产品的世界级厂商


爱尔康公司 (Alcon Laboratories, Inc.) 成立于1945年,是全球较大的眼科药品与医疗器械专业公司。在全球75个国家和地区设有分公司,拥有15,000多名员工,5个研发中心,14个生产工厂,产品销售遍及180多个国家和地区。

2008诺华公司收购眼部护理公司Alcon股份。合并完成后,爱尔康成为诺华旗下第二大的部门。视康(CIBA VISION)和选出的数种诺华眼科医药将被整合进爱尔康,从而形成销售额超过87亿美元、覆盖超过70%的眼科护理领域的组织。

爱尔康的使命是通过创新型产品,提高视觉质量,提高生活品质。这个使命意味着爱尔康22000多名员工为“保护、恢复和提高视力”的目标进行着不懈的努力与奋斗,使散光治疗,青光眼治疗,近视眼激光视力恢复矫正等等技术得到更好,努力改善更多人的视力健康。

在全球范围内,爱尔康有近2000名员工专注于研发工作,以满足世界上迫切的眼部护理需求。

此外,爱尔康与眼科保健专业人士和人道主义组织建立了紧密的合作关系,共同专注于医疗使命并在世界上需要救助的社区进行防盲活动。世界上存在着很多未解决的眼科问题,全世界有数百万人不能得到常规性眼科护理,大量实质性工作亟待完成。基于数十年的专业经验,爱尔康将继续专注于促进眼科保健行业的发展。

爱尔康于1995年作为法人实体进入中国。今天,爱尔康中国在全国范围内拥有700余名员工服务于我们的眼科保健专家。我们的企业目标是在手术产品、药品及视力保健领域成为患者的选择。爱尔康中国一贯秉承其对中国眼科医生及患者的承诺,不断加强相互间的合作,携手共创辉煌的明天。

爱尔康中国同中华医学会眼科学分会紧密合作,举办各种规模及各种类型的学术研讨会,全国眼科年会,以及国际眼科会议;为国内眼科医生的学术交流活动创造平台,为推动中国眼科事业的发展做出不懈的努力。此外,爱尔康中国还同中国残联,健康快车等慈善机构紧密合作,支持各种扶贫项目,为中国的防盲治盲工作贡献力量。


Founded in 1945 in the United States and acquired by Novartis in 2008, Alcon laboratories, Inc., a global leader in ophthalmology and a world-class manufacturer specializing in research, development, service and manufacturing of optical and ophthalmic products, was established in 1945 as the world's largest professional company of ophthalmic drugs and medical devices. It has branches in 75 countries and regions, more than 15000 employees, 5 R & D centers, 14 production plants, and product sales in more than 180 countries and regions. In 2008, Novartis acquired the shares of Alcon, an eye care company. After the merger, Alcon became the second largest division of Novartis. Cibavision and several selected Novartis ophthalmic medicines will be integrated into Alcon to form an eye care organization with sales of over $8.7 billion and coverage of over 70%. Alcon's mission is to improve visual quality and quality of life through innovative products. This mission means that more than 22000 employees of Erkang are making unremitting efforts and struggles for the goal of "protecting, restoring and improving vision", so that astigmatism treatment, glaucoma treatment, myopia laser vision restoration and correction and other technologies can be better, and efforts can be made to improve the visual health of more people. Globally, Alcon has nearly 2000 employees focused on R & D to meet the world's urgent eye care needs. In addition, Alcon has established a close partnership with eye care professionals and humanitarian organizations to focus on medical missions and carry out anti blindness activities in communities in need of assistance around the world. There are many unsolved ophthalmic problems in the world, millions of people in the world can not get routine ophthalmic care, and a lot of substantive work needs to be completed. Based on decades of professional experience, Alcon will continue to focus on promoting the development of eye care industry. Alcon entered China as a legal entity in 1995. Today, Alcon China has more than 700 employees serving our eye care experts nationwide. Our business goal is to be the choice of patients in the field of surgical products, drugs and vision care. Elkon China has always adhered to its commitment to Chinese ophthalmologists and patients, and constantly strengthened mutual cooperation to create a brilliant tomorrow hand in hand. Erkang China, in close cooperation with the ophthalmology branch of the Chinese Medical Association, has held various scale and types of academic seminars, national annual ophthalmology conference and international ophthalmology conference, created a platform for academic exchange activities of domestic ophthalmologists, and made unremitting efforts to promote the development of ophthalmology in China. In addition, elkham China has also worked closely with China Disabled Persons' Federation, health express and other charities to support various poverty alleviation projects and contribute to China's anti blindness work.

本文链接: https://brand.waitui.com/ed7309435.html 联系电话:请联系客服添加 联系邮箱:请联系客服添加

外推网广告位招租,每天只要9块9

7×24h 快讯

创历史新高!2025年中国航天发射次数达92次

记者从国家航天局获悉,2025年,我国在载人航天、深空探测、商业航天等领域完成多项突破,实现多个首次。2025年,中国航天全年发射次数达到92次,创历史新高。 (央视新闻)

2小时前

元旦假期,敦煌莫高窟客流同比上涨约30%

敦煌研究院文化弘扬部部长雷政广:从预约数据来看,今年莫高窟元旦假期的游客,增幅应该在30%左右。冬春旅游季,莫高窟的游客主要是以年轻人为主,另外散客占了90%以上的比例。同时省外游客和入境游客,增幅也比较突出。(新浪财经)

2小时前

元旦后陆续入市的公募资金规模在430亿元以上

2026年市场徐徐展开,截至2025年12月31日,元旦后陆续入市的公募资金规模在430亿元以上。一是拟于元旦后上市的16只ETF,合计资金规模近50亿元;二是于2025年11月后成立的60多只处于建仓初期的主动权益基金,合计规模约为380多亿元。 券商中国记者采访了解到,新年上市ETF的持有人,以个人投资者居多,不少产品的个人投资者持有份额占比在90%以上。从底层资金来源看,根据机构预测,居民储蓄资金入市潜力巨大。2026年非定存投资领域有望额外新增2万亿元—4万亿元左右的活化资金。 受访人士对券商中国记者表示,2026年股票投资有望继续领跑,期待居民储蓄能更显著进入股票市场。2026年科技投资难度将大于2025年,超额收益将更依赖于对产业节奏的精准把握和个股的深度甄别,挑战增加,但结构性机遇依然丰富。(e公司)

2小时前

Netflix收购华纳后拟将上映期缩至17天

1月2日,有消息称流媒体巨头Netflix希望在完成对华纳兄弟的收购后,将华纳兄弟电影的院线独占放映期缩短至17天,这一做法引发传统影院及好莱坞电影创作者的担忧。媒体称,在讨论《怪奇物语》第五季大结局院线放映表现时,好莱坞业内对Netflix所称的“行业标准放映窗口”表达了疑虑。消息人士称,Netflix一直主张17天的院线窗口期,而包括AMC在内的院线方则坚持认为应维持在目前常见的45天左右。尽管Netflix尚未最终确定此政策,且未来可能与影院院线协商出一个介于17至45天之间的折中方案,但业内普遍预期,围绕窗口期的谈判将充满张力,而Netflix的核心重点无疑是巩固其流媒体业务。(格隆汇)

2小时前

25年飞天茅台散瓶批价跌至1495元/瓶

“今日酒价”披露的最新批发参考价显示,1月3日,25年飞天茅台原箱报1505元/瓶,较上一日降20元;25年飞天茅台散瓶报1495元/瓶,较上一日降15元。(格隆汇)

2小时前

本页详细列出关于Alcon爱尔康的品牌信息,含品牌所属公司介绍,Alcon爱尔康所处行业的品牌地位及优势。
咨询